MED18
Mediator of RNA polymerase II transcription subunit 18
Also known as: FLJ20045, MED18_HUMAN, p28b, SRB5
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9BUE0
- Gene
- MED18
- Ensembl
- ENSG00000130772
- Chromosome
- 1
- Canonical length
- 208 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
MED18 is a component of the Mediator complex, which is a coactivator for DNA-binding factors that activate transcription via RNA polymerase II (Sato et al., 2003 [PubMed 12584197]).[supplied by OMIM, Oct 2008]
Canonical amino-acid sequenceUniProt
208 residues, UniProt reviewed canonical sequence.
>Q9BUE0|MED18
1 MEAPPVTMMP VTGGTINMME YLLQGSVLDH SLESLIHRLR GLCDNMEPET FLDHEMVFLL
61 KGQQASPFVL RARRSMDRAG APWHLRYLGQ PEMGDKNRHA LVRNCVDIAT SENLTDFLME
121 MGFRMDHEFV AKGHLFRKGI MKIMVYKIFR ILVPGNTDST EALSLSYLVE LSVVAPAGQD
181 MVSDDMKNFA EQLKPLVHLE KIDPKRLMLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MED18 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.33
- Highest tissue expression
- 15 nTPM
Expression across tissuesHPA
Tissue
- liver: 15 nTPM
- spleen: 9.8 nTPM
- esophagus: 9.6 nTPM
- colon: 8.9 nTPM
- small intestine: 8.9 nTPM
- skeletal muscle: 8.8 nTPM
Single-cell type
- loop of henle epithelial cells: 2.8 nCPM
- podocytes: 2.8 nCPM
- renal collecting duct principal cells: 2.8 nCPM
- gastric progenitor cells: 2.6 nCPM
- proximal tubule cells: 2.5 nCPM
- microglia: 2.4 nCPM
Immune cell
- eosinophil: 5.1 nTPM
- neutrophil: 4.9 nTPM
- non-classical monocyte: 4.2 nTPM
- plasmacytoid DC: 3.9 nTPM
- memory B-cell: 3.7 nTPM
- T-reg: 3.7 nTPM
Brain region
- choroid plexus: 5.4 nTPM
- thalamus: 4.7 nTPM
- hypothalamus: 4.5 nTPM
- white matter: 4.5 nTPM
- cerebellum: 4.4 nTPM
- medulla oblongata: 4.4 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.67
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.05
- DepMap mean gene effect
- -1
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- positive regulation of transcription elongation by RNA polymerase II
- positive regulation of transcription initiation by RNA polymerase II
- RNA polymerase II preinitiation complex assembly
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Mediator complex, subunit Med18
- Med18 protein
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of MED18 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MED18 as an antibody target. Whether an autoantibody or antibody against MED18 could matter depends on whether native MED18 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MED18 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MED18 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...